MSL
PBYI icon

Mackay Shields LLC’s Puma Biotechnology PBYI Stock Holding History

Mackay Shields LLC’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,683
Closed -$531K – 1479
2019
Q1 		$531K Buy
13,683
+2,500
+22% +$76.4K ﹤0.01% 1162
2018
Q4 		$228K Sell
11,183
-1,224
-10% -$36.7K ﹤0.01% 1291
2018
Q3 		$569K Buy
12,407
+800
+7% +$38.6K ﹤0.01% 985
2018
Q2 		$687K Buy
11,607
+200
+2% +$11.6K ﹤0.01% 1034
2018
Q1 		$776K Buy
+11,407
New +$854K ﹤0.01% 1038

Other funds holding PBYI

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mackay Shields LLC's PBYI Position: Q2 2019 in Review

Mackay Shields LLC sold out of Puma Biotechnology (PBYI) in Q2 2019, closing a stake of 13,683 shares — an estimated $531K sold.

Mackay Shields LLC first reported a position in PBYI in Q1 2018 and held it in 5 quarters. The position peaked at $776K in Q1 2018. 139 funds tracked by Wall St. Rank hold PBYI as of Q2 2019.

  • Mackay Shields LLC reported no remaining Puma Biotechnology position as of Q2 2019 after selling out during the quarter.
  • Mackay Shields LLC sold 13,683 Puma Biotechnology shares in Q2 2019, an estimated $531K.
  • Mackay Shields LLC first reported a position in Puma Biotechnology in Q1 2018 and held it in 5 quarters.
  • Mackay Shields LLC's Puma Biotechnology position peaked at $776K in Q1 2018.
  • 139 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2019.

Based on Mackay Shields LLC's 13F filing for Q2 2019, filed 13 Aug 2019.